Variable
Non-adherence (n=9) Adherence (n=91)
p-value
Gender Male (n=61) Female (n=34) 6 (66.7%) 3 (33.3%) 55# (60.4%) 31# (34.1%) 0.872 (Pierson’s Chi2 test)
Indication Atrial fibrillation Venous thromboembolism Other 9 (100%) 0 (0%) 0 (0%) 72 (79.1%) 11 (12.1%) 8 (8.8%) 0.244 (Pierson’s Chi2 test)
DOAC Apixaban Dabigatran Edoxaban Rivaroxaban 2 (22.2%) 2 (22.2%) 2 (22.2%) 3 (33.3%) 17(18.7%) 12 (13.2%) 34 (37.4%) 28 (30.1%) 0.784 (Pierson’s Chi2 test)
Dosage Once a day Twice a day 5 (55.6%) 4 (44.4%) 62 (68.1%) 29 (31.9%) 0.444 (Pierson’s Chi2 test)